Drug treatment of osteoporosis
Dambacher, M.A.; Haas, H.G.; Lauffenburger, T.; Olah, A.J.
Therapeutische Umschau. Revue Therapeutique 34(9): 655-662
1977
ISSN/ISBN: 0040-5930 PMID: 905964 Document Number: 123217
Document emailed within 1 workday
Related Documents
Halbekath, J. 2000: Drug treatment for the treatment of primary osteoporosis Zeitschrift für Arztliche Fortbildung und Qualitatssicherung 94(6): 453-460Soen, S. 2007: First choice drug for treatment of osteoporosis and the strategic points for choice of drugs Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 9): 325-328
Nakamura, T. 2008: Assessment of bone quality. Drug developments for restoring bone mass and quality in the treatment of osteoporosis Clinical Calcium 18(3): 374-380
Tanaka, Y. 2007: Drug-induced osteoporosis Nihon Rinsho. Japanese Journal of Clinical Medicine 65(Suppl 8): 394-398
2005: Strontium: new drug. Postmenopausal osteoporosis: too many unknowns Prescrire international 14(80): 207-211
Wynn, R.L. 2000: Osteoporosis, alveolar bone loss, and drug development General Dentistry 48(3): 218-222; 224-225
Bolander, F.F. 2010: Intelligent design: drug targets for the prevention of osteoporosis Current Opinion in Investigational Drugs 11(4): 382-384
Miller, P.D. 1996: Critical drug appraisal: etidronate intermittent cyclic therapy for postmenopausal osteoporosis British Journal of Clinical Practice 50(1): 23-31
Eiken, P.A.; Langdahl, B.L.; Eiken, F.L.; Walter, S.; Poulsen, M.Hvid.; Abrahamsen, B. 2011: Prevention and treatment of osteoporosis during treatment of non-metastatic prostate cancer Ugeskrift for Laeger 173(48): 3093-3096
Pongchaiyakul, C.; Wanothayaroj, E. 2007: Performance of the Khon Kaen Osteoporosis Study (KKOS) score for identifying osteoporosis in men Journal of the Medical Association of Thailand 90(8): 1518-1523
Robin, J.C.; Ambrus, J.L. 1982: Studies on osteoporosis VI. Effect of human and salmon calcitonin on experimental osteoporosis Research Communications in Chemical Pathology and Pharmacology 35(3): 491-498
Robin, J.C.; Sirianni, S.R.; Pragay, D.A.; Ambrus, J.L. 1981: Studies on osteoporosis. V. Comparison of methods of evaluation of osteoporosis and study of chromosome changes induced by neutron activation Journal of Medicine 12(4): 251-256
Zhang, X.; Lin, J.; Yang, X.; Fei, Q.; Wang, B.; Yang, Y.; Li, J.; Ma, Z.; Zhao, F.; Wang, Q. 2015: Investigation of osteoporosis prevalence and osteoporosis-related clinical risk factors among healthy elderly male Zhonghua Yi Xue Za Zhi 95(41): 3366-3369
Suzuki, Y.; Wakabayashi, T. 2015: Management of osteoporosis associated with rheumatoid arthritis and glucocorticoid-induced osteoporosis Clinical Calcium 25(12): 1825-1834
Syc, S. 1971: Causes of cortisol-induced osteoporosis and Cushing's disease osteoporosis Wiadomosci Lekarskie 24(1): 41-43
Joseph, P.; Hughes, D. 1997: Osteoporosis. Guidelines for general practitioners. Osteoporosis Australia Australian Family Physician 26(10): 1181-5 1188-91 1194-6
Spencer, H.; Kramer, L. 1986: NIH Consensus Conference: osteoporosis. Factors contributing to osteoporosis Journal of Nutrition 116(2): 316-319
Rabinovich, S.A. 1976: Drug resistance of malaria parasites. 2. Clinical aspects, drug treatment and prevention of drug-resistant malaria Meditsinskaia Parazitologiia i Parazitarnye Bolezni 45(6): 731-737
Uebelhart, B.; Rizzoli, R.é 2007: Osteoporosis treatment Revue Medicale Suisse 3(94): 150-153
Villiaumey, J.; Hioco, D.; Larget-Piet, B. 1979: The treatment of osteoporosis Annales de Medecine Interne 130(3): 159-163